EUVIMEDAvasta EUVIMED
Crossref

Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors

New Materials, Compounds and Applications · 2026-04-03

DOI: 10.62476/nmca.10165 ↗

At a glance

Journal article in New Materials, Compounds and Applications, published online on 2026-04-03.

AbstraktBibliograafilised andmedCiteRelated studies

Abstract (original language)

Kokkuvõte pole saadaval.

Cite

APA

(2026). Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. https://doi.org/10.62476/nmca.10165

Vancouver

Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. 2026. doi:10.62476/nmca.10165

BibTeX
@article{euvimed2026,
  title = {Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors},
  journal = {New Materials, Compounds and Applications},
  year = {2026},
  doi = {10.62476/nmca.10165}
}
Start for free →